FASEB J. FASEB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.08-121657.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Buy
Right arrow All Versions of this Article:
fj.08-121657v1
fj.08-121657v2
23/9/2942    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McLeod, J.
Right arrow Articles by Genever, P. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McLeod, J.
Right arrow Articles by Genever, P. G.
(The FASEB Journal. 2009;23:2942-2955.)
© 2009 FASEB

{gamma}-Secretase-dependent cleavage of amyloid precursor protein regulates osteoblast behavior

Jane McLeod*, Neil Curtis{dagger}, Huw D. Lewis{ddagger}, Mark A. Good§, Michael J. Fagan{dagger} and Paul G. Genever*,1

* Biomedical Tissue Research, Department of Biology, University of York, York, UK;

{dagger} Department of Engineering, University of Hull, Hull, UK;

{ddagger} Department of Molecular and Cellular Neuroscience, Merck Sharp and Dohme Research Laboratories, Harlow, UK; and

§ School of Psychology, Cardiff University, Cardiff, UK

1 Correspondence: Department of Biology (Area 9), University of York, York, YO10 5YW, UK. E-mail: pg5{at}york.ac.uk

{gamma}-Secretase cleaves amyloid precursor protein (APP) to generate amyloid-β (Aβ) peptides, which aggregate in the brain in Alzheimer’s disease (AD). {gamma}-Secretase also cleaves molecules that regulate osteoblast activity, such as Notch and ephrinB2. However, the role of APP in bone is unknown. In this study, the expression, cleavage, and function of APP were investigated during osteogenesis in vitro and in vivo. Expression of all {gamma}-secretase subunits was confirmed in human primary osteoprogenitors cells, and a significant increase in enzyme activity was observed during osteogenic differentiation using a specific fluorimetric assay. Application of selective inhibitors confirmed {gamma}-secretase-dependent cleavage of APP within osteogenic cells, and secretion of Aβ by mature osteoblasts was demonstrated with the use of a chemiluminescent immunoassay. Osteoprogenitors showed a selective and significant increase in adhesion to extracellular matrices containing aged Aβ plaques compared with nonaged Aβ peptide controls. Aβ on the endosteal and periosteal surfaces of adult rat ulnae were identified by immunohistochemistry. MicroCT analysis of vertebrae from an AD mouse model, Tg2576, identified a decrease in bone volume, surface area, and thickness compared with wild-type controls. These findings indicate that APP functions as a novel regulator of osteoblast activity and suggest that the mechanisms underlying the pathogenesis of AD may also influence bone.—McLeod, J., Curtis, N., Lewis, H. D., Good, M. A., Fagan, M. J., Genever, P. G. {gamma}-Secretase-dependent cleavage of amyloid precursor protein regulates osteoblast behavior.


Key Words: Alzheimer’s disease • mesenchymal stem cell







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by The Federation of American Societies for Experimental Biology.